Misset JL - Search Results

1

Phase II study of oxaliplatin versus oxaliplatin combined with infusional 5-fluorouracil in hormone refractory metastatic prostate cancer patients.

Droz JP, Muracciole X, Mottet N, Ould Kaci M, Vannetzel JM, Albin N, Culine S, Rodier JM, Misset JL, Mackenzie S, Cvitkovic E, Benoit G. Droz JP, et al. Among authors: misset jl. Ann Oncol. 2003 Aug;14(8):1291-8. doi: 10.1093/annonc/mdg342. Ann Oncol. 2003. PMID: 12881395 Free article. Clinical Trial.

2

Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients.

Zelek L, Cottu P, Tubiana-Hulin M, Vannetzel JM, Chollet P, Misset JL, Chouaki N, Marty M, Gamelin E, Culine S, Dieras V, Mackenzie S, Spielmann M. Zelek L, et al. Among authors: misset jl. J Clin Oncol. 2002 May 15;20(10):2551-8. doi: 10.1200/JCO.2002.06.164. J Clin Oncol. 2002. PMID: 12011135 Clinical Trial.

3

Phase I and pharmacological study of an oxaliplatin and carboplatin combination in advanced malignancies.

Mita C, Chatelut E, Bekradda M, Soulié P, Canal P, Misset JL, Cvitkovic E, Bugat R. Mita C, et al. Among authors: misset jl. Ann Oncol. 2003 Dec;14(12):1776-82. doi: 10.1093/annonc/mdg490. Ann Oncol. 2003. PMID: 14630684 Free article. Clinical Trial.

4

Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: a phase I study in advanced gastrointestinal cancer patients.

Goldwasser F, Gross-Goupil M, Tigaud JM, Di Palma M, Marceau-Suissa J, Wasserman E, Yovine A, Misset JL, Cvitkovic E. Goldwasser F, et al. Among authors: misset jl. Ann Oncol. 2000 Nov;11(11):1463-70. doi: 10.1023/a:1026535824044. Ann Oncol. 2000. PMID: 11142487 Free article. Clinical Trial.

5

Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II study.

Monnet I, de CH, Soulié P, Saltiel-Voisin S, Bekradda M, Saltiel JC, Brain E, Rixe O, Yataghene Y, Misset JL, Cvitkovic E. Monnet I, et al. Among authors: misset jl. Ann Oncol. 2002 Jan;13(1):103-7. doi: 10.1093/annonc/mdf006. Ann Oncol. 2002. PMID: 11863089 Free article. Clinical Trial.

6

Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer.

Ganem G, Tubiana-Hulin M, Fumoleau P, Combe M, Misset JL, Vannetzel JM, Bachelot T, De Ybarlucea LR, Lotz V, Bendahmane B, Dieras V. Ganem G, et al. Among authors: misset jl. Ann Oncol. 2003 Nov;14(11):1623-8. doi: 10.1093/annonc/mdg449. Ann Oncol. 2003. PMID: 14581269 Free article. Clinical Trial.

7

Exacerbation of oxaliplatin neurosensory toxicity following surgery.

Gornet JM, Savier E, Lokiec F, Cvitkovic E, Misset JL, Goldwasser F. Gornet JM, et al. Among authors: misset jl. Ann Oncol. 2002 Aug;13(8):1315-8. doi: 10.1093/annonc/mdf254. Ann Oncol. 2002. PMID: 12181257 Free article.

8

Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity.

Lévi F, Benavides M, Chevelle C, Le Saunier F, Bailleul F, Misset JL, Regensberg C, Vannetzel JM, Reinberg A, Mathé G. Lévi F, et al. Among authors: misset jl. J Clin Oncol. 1990 Apr;8(4):705-14. doi: 10.1200/JCO.1990.8.4.705. J Clin Oncol. 1990. PMID: 2179481 Clinical Trial.

9

Circadian rhythm-modulated (CRM) chemotherapy of metastatic breast cancer with mitoxantrone, 5-fluorouracil, and folinic acid: preliminary results of a phase I trial.

Deprés-Brummer P, Berthault-Cvitkovic F, Lĕvi F, Brienza S, Vannetzel JM, Jasmin C, Misset JL. Deprés-Brummer P, et al. Among authors: misset jl. J Infus Chemother. 1995;5(3 Suppl 1):144-7. J Infus Chemother. 1995. PMID: 8528975 Clinical Trial.

10

Schedule-dependent paclitaxel tolerance/activity: data from a 7 day infusion phase I study with pharmacokinetics in paclitaxel refractory ovarian cancer.

Soulié P, Trandafir L, Taamma A, Lokiec F, Brain E, Delord JP, Mita A, Vannetzel JM, Cvitkovic E, Misset JL. Soulié P, et al. Among authors: misset jl. Anticancer Drugs. 1997 Sep;8(8):763-6. doi: 10.1097/00001813-199709000-00005. Anticancer Drugs. 1997. PMID: 9396620 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters